Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-01-23
1988-02-16
Fan, Jane T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549310, C07D30788, A61K 3144
Patent
active
047256222
ABSTRACT:
A method of treating rheumatoid arthritis which method comprises administering to a mammal in need of such treatment a therapeutically effective amount of a compound of the formula: ##STR1## and the pharmaceutically acceptable salts thereof, wherein:
REFERENCES:
patent: 3705894 (1972-12-01), Gerzon et al.
patent: 3777020 (1973-12-01), Johnson
patent: 3853919 (1974-12-01), Mori et al.
patent: 3868454 (1975-02-01), Johnson
patent: 3880995 (1975-04-01), Jones
patent: 3903071 (1975-09-01), Holmes
J. Antibiotics, vol. 29, pp. 275-285, pp. 286-291, (1976).
Cancer Research, vol. 36, pp. 2923-2927, (1976).
Allison Anthony C.
Eugui Elsie M.
Muchowski Joseph M.
Nelson Peter H.
Fan Jane T.
Moran Tom M.
Syntex (U.S.A.) Inc.
Wise Ellen J.
LandOfFree
Mycophenolic acid derivatives in the treatment of rheumatoid art does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mycophenolic acid derivatives in the treatment of rheumatoid art, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mycophenolic acid derivatives in the treatment of rheumatoid art will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2221497